Nicholas Morrell

Nicholas Morrell

University of Cambridge

H-index: 102

Europe-United Kingdom

About Nicholas Morrell

Nicholas Morrell, With an exceptional h-index of 102 and a recent h-index of 62 (since 2020), a distinguished researcher at University of Cambridge, specializes in the field of Medicine.

His recent articles reflect a diverse array of research interests and contributions to the field:

Therapeutic use of bone morphogenetic proteins

Allele-specific control of rodent and human lncRNA KMT2E-AS1 promotes hypoxic endothelial pathology in pulmonary hypertension

Blood DNA methylation profiling identifies cathepsin Z dysregulation in pulmonary arterial hypertension

Integrative Multiomics in the Lung Reveals a Protective Role of Asporin in Pulmonary Arterial Hypertension

Understanding what drives genetic study participation: Perspectives of patients, carers, and relatives

ATP13A3 variants promote pulmonary arterial hypertension by disrupting polyamine transport

Functional validation of EIF2AK4 (GCN2) missense variants associated with pulmonary arterial hypertension

Shared and Distinct Genomics of Chronic Thromboembolic Pulmonary Hypertension and Pulmonary Embolism

Nicholas Morrell Information

University

Position

___

Citations(all)

37850

Citations(since 2020)

15571

Cited By

28823

hIndex(all)

102

hIndex(since 2020)

62

i10Index(all)

283

i10Index(since 2020)

226

Email

University Profile Page

University of Cambridge

Google Scholar

View Google Scholar Profile

Nicholas Morrell Skills & Research Interests

Medicine

Top articles of Nicholas Morrell

Title

Journal

Author(s)

Publication Date

Therapeutic use of bone morphogenetic proteins

2024/2/8

Allele-specific control of rodent and human lncRNA KMT2E-AS1 promotes hypoxic endothelial pathology in pulmonary hypertension

Science Translational Medicine

Yi-Yin Tai

Qiujun Yu

Ying Tang

Wei Sun

Neil J Kelly

...

2024/1/10

Blood DNA methylation profiling identifies cathepsin Z dysregulation in pulmonary arterial hypertension

Nature Communications

Anna Ulrich

Yukyee Wu

Harmen Draisma

John Wharton

Emilia M Swietlik

...

2024/1/6

Integrative Multiomics in the Lung Reveals a Protective Role of Asporin in Pulmonary Arterial Hypertension

J Hong

L Medzikovic

W Sun

G Ruffenach

B Wong

...

2024/5

Understanding what drives genetic study participation: Perspectives of patients, carers, and relatives

Pulmonary Circulation

Emilia M Swietlik

Michaela Fay

Nicholas W Morrell

2024/1

ATP13A3 variants promote pulmonary arterial hypertension by disrupting polyamine transport

Cardiovascular Research

Bin Liu

Mujahid Azfar

Ekaterina Legchenko

James A West

Shaun Martin

...

2024/4/16

Functional validation of EIF2AK4 (GCN2) missense variants associated with pulmonary arterial hypertension

bioRxiv

Giulia Emanuelli

JiaYi Zhu

Nicholas Morrell

Stefan J Marciniak

2024

Shared and Distinct Genomics of Chronic Thromboembolic Pulmonary Hypertension and Pulmonary Embolism

American Journal of Respiratory and Critical Care Medicine

James Liley

Michael Newnham

Marta Bleda

Katherine Bunclark

William Auger

...

2024/3/12

Unlocking the potential of genetic research in pulmonary arterial hypertension: Insights from clinicians, researchers, and study team

Pulmonary Circulation

Emilia M Swietlik

Michaela Fay

Nicholas W Morrell

2024/1

A rare homozygous missense GDF2 (BMP9) mutation causing PAH in siblings: Does BMP10 status contribute?

American Journal of Medical Genetics Part A

Paul Upton

Susan Richards

Angela Bates

Karen Y Niederhoffer

Nicholas W Morrell

...

2023/1

Circulating markers of inflammation and angiogenesis and clinical outcomes across subtypes of pulmonary arterial hypertension

The Journal of Heart and Lung Transplantation

Kellen Hirsch

Stephanie Nolley

David D Ralph

Ying Zheng

William A Altemeier

...

2023/2/1

MGX292, A Novel Variant of Native Bone Morphogenetic Protein 9 (BMP9) That Lacks Osteogenic Activity, Reverses Vascular Remodelling and Pulmonary Arterial Hypertension in the …

NW Morrell

DJ Grainger

R Salmon

J Reckless

PD Upton

...

2023/5

The role of BMP9-induced Sema3G in pulmonary vascular stability

Sarah Mirza

Benjamin Dunmore

Nicholas Morrell

2023/9/9

Allosteric Inhibition Restricts Motion of the SMURF1 Glycine Hinge and Reverses Experimental Pulmonary Arterial Hypertension

Circulation

Alex M Rothman

Amir Florentin

Catherine Quigley

Florence Zink

Olivier Bonneau

...

2023/11/7

Endothelial Bone Morphogenetic Protein Signaling in Pulmonary Arterial Hypertension

Wei Li

Nicholas W Morrell

2023/1/1

Integrative Multiomics to Dissect the Lung Transcriptional Landscape of Pulmonary Arterial Hypertension

bioRxiv

Jason Hong

Brenda Wong

Christopher J Rhodes

Zeyneb Kurt

Tae-Hwi Schwantes-An

...

2023/1/16

High concentrations of soluble endoglin can inhibit BMP9 signaling in non-endothelial cells

Scientific Reports

Clara Andersson-Rusch

Bin Liu

Ingrid Quist-Løkken

Paul D Upton

Oddrun Elise Olsen

...

2023/4/24

CTEPH has shared and distinct genetic associations with pulmonary embolism in a genome-wide association study

medRxiv

James Liley

Michael Newnham

Marta Bleda

Katherine Bunclark

William Auger

...

2023/6/5

P146 Survival of IPAH patients with and without comorbidity

SA Reddy

GJ Polwarth

S Graf

NW Morrell

EMD De Bie

...

2023/11/1

BMPR2 Mutation and Metabolic Reprogramming in Pulmonary Arterial Hypertension

Iona Cuthbertson

Nicholas W Morrell

Paola Caruso

2023/1/6

See List of Professors in Nicholas Morrell University(University of Cambridge)